Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00239135 · ClinicalTrials.gov registry record · Phase 2
Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel
A Phase 2 study, sponsored by Peplin.
- Completed
- Registry status
- Phase 2
- Development phase
- 34
- Enrollment target
NCT00239135: Completed Phase 2 study, sponsored by Peplin.
NCT00239135 is a Phase 2 study that has completed, run by Peplin. The registered enrollment target is 34 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00239135, a Phase 2 study, has completed, sponsored by Peplin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is : * To determine the maximum tolerated dose (MTD) for PEP005 Topical Gel in patients with actinic keratoses. * To evaluate patients for clinical safety * To determine the systemic absorption of PEP005 Topical Gel
Interventions
- DRUG PEP005
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2005-09 |
| Est. Completion | 2005-12 |
| Phase | Phase 2 |
What the finished NCT00239135 record still lists
NCT00239135 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which PEP005 is the first listed.
NCT00239135 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00239135 about?
NCT00239135 is a clinical study titled "Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel". The purpose of this study is : * To determine the maximum tolerated dose (MTD) for PEP005 Topical Gel in patients with actinic keratoses. * To evaluate patients for clinical safety * To determine the systemic absorption of PEP005 Topical Gel
What is the current status of trial NCT00239135?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2005-09. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00239135?
The interventions under investigation include: PEP005 (DRUG).
Who is sponsoring clinical trial NCT00239135?
This trial is sponsored by Peplin, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00239135's enrollment target sits among peer trials
34 1539th of 2000 higher than 448 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia